Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL pathway blocker

Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL pathway blocker

US Patent 10624891 · Granted Apr 21, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Security analysis system and method based on negative testing for protocol imple2025
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2025
Composition for treating or preventing colitis by NAMPT metabolic regulation2025
Early detection marker for degenerative osteoarthritis with TRIM24-RIP3 axis2024
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2024
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2023
Composition for anticancer adjuvant comprising RIP3 expression promoter as activ2021
Anticancer adjuvant composition containing RIP3 expression promoter as active in2019
Method of preventing or treating skin necroptosis disease comprising RIP3-MLKL p2018
Gut flora-derived extracellular vesicles, and method for searching for a disease2016
Gut flora-derived extracellular vesicles, and method for searching for a disease2015
Object detection device and system2013